Home  ›  Access Bio  ›  CareStart™ Rapid Antigen Test Kit (FDA/EUA)
CareStart™ Rapid Antigen Test Kit (FDA/EUA)
CareStart™ Rapid Antigen Test Kit (FDA/EUA)
CareStart™ Rapid Antigen Test Kit (FDA/EUA)
CareStart™ Rapid Antigen Test Kit (FDA/EUA)
CareStart™ Rapid Antigen Test Kit (FDA/EUA)

CareStart™ Rapid Antigen Test Kit (FDA/EUA)

Regular price $395.00
Sale price $395.00 Regular price $500.00
Unit price
Save 21%
In Stock
Rendering loop-subscriptions
  • Lateral flow assay
  • Detect SARS-CoV-2 nucleocapsid protein antigen
  • Rapid results within 10-15 minutes
  • For use under the Emergency Use Authorization (EUA)
Choose your purchase type:

Subscription Details:

  • Save 10-15% on all subscription orders!
  • Cancel anytime from your customer portal.
  • Super flexible subscription controls.
  • SMS/email notifications on upcoming orders.
  • Choose your delivery schedule:
Pickup available at PHARMALYNK WAREHOUSE

Usually ready in 4 hours

  • All orders ship the same day (Free $250+)

  • Save 10% — on auto-renew orders.

  • Wholesale Program available

The Access Bio, Inc. CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider. As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart™ COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike.

Because access is everything.

Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. Based on the greatest needs and the potential to do the most good, we work with partners across the world.

FAQs

The CareStart™ COVID-19 Antigen is a type of test called an antigen test. Antigen tests are designed to detect proteins from the virus that causes COVID-19 in nasopharyngeal or anterior nasal swab samples collected by a healthcare provider.

Testing of your specimen(s) will help find out if you may have COVID-19.

If you have a positive test result with the CareStart™ COVID-19 Antigen test, it is very likely that you have COVID-19 because proteins from the virus that causes COVID-19 were found in your sample. Therefore, it is also likely that you may be placed in isolation to avoid spreading the virus to others. You should follow CDC guidance to reduce the potential transmission of disease.

Eighty-three percent of adults and 87% of children were asymptomatic. CareStart sensitivity/specificity were 84.8% (95% confidence interval [CI], 71.1–93.7)/97.2% (95% CI, 92.0–99.4) and 85.7% (95% CI, 42.1–99.6)/89.5% (95% CI, 66.9–98.7) in adults and children, respectively, within 5 days of symptoms.

About Access Bio
Because access is everything.
Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. Based on the greatest needs and the potential to do the most good, we work with partners across the world.
Shop all Access Bio